A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

Researchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

A study at the BCS conference in Manchester 2023 reveals that serious heart attacks are more likely on Mondays. Researchers ...

Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...

Electrocardiogram (ECG) during a myocardial infarction (heart attack). Computer illustration showing ST-elevation which is measured at the junctional or J-point. Each year approximately 750,000 people ...

While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...

"Later that day, I had a phone call to say that I had had a heart attack and that they were expecting me in A&E. I spent five ...

IV = intravenous; NSTEMI = non-ST segment elevation myocardial infarction; P2Y12 = purinergic receptor P2Y, G-protein coupled, 12 protein; PCI = percutaneous coronary intervention.